- Identify the therapeutic strategies , products , and companies that dominate the current marketed products landscape and recognize gaps and areas of unmet need .
- Identify key pipeline trends in molecule type , administration route , mechanism of action , and novelty .
- Consider market opportunities and potential risks by examining trends in breast cancer clinical trial size , duration , and failure rate by stage of development , molecule type , and mechanism of action .
- Recognize the late-stage pipeline molecules that have demonstrated strong therapeutic potential in breast cancer by examining clinical trial data and multi-scenario product forecast projections .
- Compare treatment usage patterns , annual therapy costs , and market growth projections for the US , Canada , the UK , France , Germany , Italy , Spain , and Japan .
- Discover trends in licensing and co-development deals concerning breast cancer products and identify the major strategic consolidations that have shaped the commercial landscape . Ask for Discount at – http :// www . absolutereports . com / enquiry / request-discount / 10070569 1 Table of Contents
1 Table of Contents 4 1.1 List of Tables 7 1.2 List of Figures 7 2 Introduction 9 2.1 Disease Introduction 9 2.2 Symptoms 10 2.3 Etiology 10 2.4 Pathophysiology 11 2.5 Epidemiology 12 2.6 Diagnosis and Classification 14 2.7 Prognosis and Disease Staging 15 2.8 Treatment Options 17 2.8.1 Surgery and Radiation Therapy 18
2.8.2 Chemotherapy 18 2.8.3 Hormonal Therapies 19